Literature DB >> 17958441

Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids.

Julie Thevenot1, Anne-Lise Troutier, Laurent David, Thierry Delair, Catherine Ladavière.   

Abstract

Biocompatible and biodegradable assemblies consisting of spherical particles coated with lipid layers were prepared from sub-micrometer poly(lactic acid) particles and lipid mixtures composed of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine and 1,2-dipalmitoyl-3-trimethylammonium-propane. These original colloidal assemblies, named LipoParticles, are of a great interest in biotechnology and biomedicine. Nevertheless, a major limitation of their use is their poor colloidal stability toward ionic strength. Indeed, electrostatic repulsions failed to stabilize LipoParticles in aqueous solutions containing more than 10 mM NaCl. By analogy with the extensive use of poly(ethylene glycol) (PEG)-lipid conjugates to improve the circulation lifetime of liposomes in vivo, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)] with various PEG chain lengths was added to the lipid formulation. Here, we show that LipoParticle stabilization was enhanced at least up to 150 mM NaCl (for more than 1 year at 4 degrees C). To determine the structure of PEG-modified LipoParticles as a function of the PEG chain length and the PEG-lipid fraction in the lipid formulation, a thorough physicochemical characterization was carried out by means of many techniques including quasi-elastic light scattering, zeta potential measurements, transmission electron microscopy, 1H NMR spectroscopy, and small-angle X-ray scattering. Finally, an attempt was made to link the resulting structural data to the colloidal behavior of PEG-modified LipoParticles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17958441     DOI: 10.1021/bm700753q

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  28 in total

1.  Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer.

Authors:  Warefta Hasan; Kevin Chu; Anuradha Gullapalli; Stuart S Dunn; Elizabeth M Enlow; J Christopher Luft; Shaomin Tian; Mary E Napier; Patrick D Pohlhaus; Jason P Rolland; Joseph M DeSimone
Journal:  Nano Lett       Date:  2011-12-21       Impact factor: 11.189

2.  Preparation of particulate polymeric therapeutics for medical applications.

Authors:  Jia Zhuang; Ronnie H Fang; Liangfang Zhang
Journal:  Small Methods       Date:  2017-07-25

3.  New functional degradable and bio-compatible nanoparticles based on poly(malic acid) derivatives for site-specific anti-cancer drug delivery.

Authors:  Zhi Wei Huang; Véronique Laurent; Ghizlane Chetouani; Julia Y Ljubimova; Eggehard Holler; Thierry Benvegnu; Pascal Loyer; Sandrine Cammas-Marion
Journal:  Int J Pharm       Date:  2011-04-27       Impact factor: 5.875

4.  Noncovalent polymerization of mesogens crystallizes lysozyme: correlation between nonamphiphilic lyotropic liquid crystal phase and protein crystal formation.

Authors:  Karen A Simon; Gauri S Shetye; Ulrich Englich; Lei Wu; Yan-Yeung Luk
Journal:  Langmuir       Date:  2011-08-04       Impact factor: 3.882

5.  Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing.

Authors:  Pedro M Valencia; Pamela A Basto; Liangfang Zhang; Minsoung Rhee; Robert Langer; Omid C Farokhzad; Rohit Karnik
Journal:  ACS Nano       Date:  2010-03-23       Impact factor: 15.881

Review 6.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

7.  Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.

Authors:  Liangfang Zhang; Juliana M Chan; Frank X Gu; June-Wha Rhee; Andrew Z Wang; Aleksandar F Radovic-Moreno; Frank Alexis; Robert Langer; Omid C Farokhzad
Journal:  ACS Nano       Date:  2008-08       Impact factor: 15.881

8.  Lecithin and PLGA-based self-assembled nanocomposite, Lecithmer: preparation, characterization, and pharmacokinetic/pharmacodynamic evaluation.

Authors:  Seby Elsy Varghese; Mayur K Fariya; Gopal Singh Rajawat; Frank Steiniger; Alfred Fahr; Mangal S Nagarsenker
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

9.  Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy.

Authors:  Jason Park; Stephen H Wrzesinski; Eric Stern; Michael Look; Jason Criscione; Ragy Ragheb; Steven M Jay; Stacey L Demento; Atu Agawu; Paula Licona Limon; Anthony F Ferrandino; David Gonzalez; Ann Habermann; Richard A Flavell; Tarek M Fahmy
Journal:  Nat Mater       Date:  2012-07-15       Impact factor: 43.841

Review 10.  Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Authors:  Hongkee Sah; Laura A Thoma; Hari R Desu; Edel Sah; George C Wood
Journal:  Int J Nanomedicine       Date:  2013-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.